Huang, Jie
Eisai (United States)
3 papers on CoChatORCID 0000-0002-8652-4934
Most cited papers
- Verified
The clinical effects of inclisiran, a first-in-class LDL-C lowering siRNA therapy, on the LDL-C levels in Chinese patients with hypercholesterolemia
Luo, Z., Huang, Z., Sun, F., Guo, F., Wang, Y., Kao, S., Yang, G., Huang, J., Li, J., Zhao, S., et al. (2023) · Journal of Clinical Lipidology
Lipoproteins and Cardiovascular HealthCholesterol and Lipid Metabolism
Cited by 38
- Verified
Lenvatinib Plus Ifosfamide and Etoposide in Children and Young Adults With Relapsed Osteosarcoma
Gaspar, N., Hung, G.-Y., Strauss, S. J., Campbell-Hewson, Q., Dela Cruz, F. S., Glade Bender, J. L., Koh, K.-N., Whittle, S. B., Chan, G. C.-F., Gerber, N. U., et al. (2024) · JAMA Oncology
Sarcoma Diagnosis and TreatmentBone Tumor Diagnosis and Treatments
Cited by 28
- Verified
OLIE, ITCC-082: A Phase II Trial of Lenvatinib Plus Ifosfamide and Etoposide in Relapsed/Refractory Osteosarcoma
Gaspar, N., Campbell-Hewson, Q., Huang, J., Okpara, C. E., & Bautista, F. (2021) · Future Oncology
Sarcoma Diagnosis and TreatmentBone Tumor Diagnosis and Treatments
Cited by 9
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free